Sanofi To Get Grants For Marketing It’s TB Drug In India
Posted by
www.biotecnika.org
Sanofi TB Drug In India Sanofi is likely to be granted marketing
authorization for its new anti-tuberculosis medicine rifapentine India
soon. The Subject Experts Committee (SEC) for Antimicrobials &
Antivirals has reportedly recommended CDSCO to grant conditional
approval to import and market rifapentine. The Central Drugs Standard
Control Organization is the primary drug regulator in […]
The post Sanofi To Get Grants For Marketing It's TB Drug In India
appeared first on Rasayanika .
https://www.rasayanika.com/2019/11/06/sanofi-to-get-grants-for-marketing-its-tb-drug-in-india/
Uncategorized
Subscribe to:
Post Comments (Atom)
Post a Comment